TOKYO, Feb 10 — A Japanese Health Ministry committee has approved the oral Covid-19 drug made by US drugmaker Pfizer Inc, the ministry said in a statement tomorrow.
Jiji news agency said final approval of the drug for use, which officials had said they expected would come around mid-February, could come as early as tomorrow night under emergency approval measures.
Pfizer applied for approval in January. — Reuters
